Nanoparticle drug delivery systems for synergistic delivery of tumor therapy
Frontiers in Pharmacology · 16.02.2023 · 14
DOI: 10.3389/fphar.2023.1111991 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 16.02.2023. Verfasst von Daoyuan Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation…. Die Arbeit wurde bisher 111-mal zitiert (Crossref) und nennt 240 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nanoparticle drug delivery systems have proved anti-tumor effects; however, they are not widely used in tumor therapy due to insufficient ability to target specific sites, multidrug resistance to anti-tumor drugs, and the high toxicity of the drugs. With the development of RNAi technology, nucleic acids have been delivered to target sites to replace or correct defective genes or knock down specific genes. Also, synergistic therapeutic effects can be achieved for combined drug delivery, which is more effective for overcoming multidrug resistance of cancer cells. These combination therapies achieve better therapeutic effects than delivering nucleic acids or chemotherapeutic drugs alone, so the scope of combined drug delivery has also been expanded to three aspects: drug-drug, drug-gene, and gene-gene. This review summarizes the recent advances of nanocarriers to co-delivery agents, including i) the characterization and preparation of nanocarriers, such as lipid-based nanocarriers, polymer nanocarriers, and inorganic delivery carriers; ii) the advantages and disadvantages of synergistic delivery approaches; iii) the effectual delivery cases that are applied in the synergistic delivery systems; and iv) future perspectives in the design of nanoparticle drug delivery systems to co-deliver therapeutic agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universi…
- Shandong Boan Biotechnology Co., Ltd., Yantai, China.
Zitieren
APA
Chen, D., Liu, X., Lu, X., & Tian, J. (2023). Nanoparticle drug delivery systems for synergistic delivery of tumor therapy. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1111991
Vancouver
Chen D, Liu X, Lu X, Tian J. Nanoparticle drug delivery systems for synergistic delivery of tumor therapy. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1111991
BibTeX
@article{Chen2023,
author = {Chen, Daoyuan and Liu, Xuecun and Lu, Xiaoyan and Tian, Jingwei},
title = {Nanoparticle drug delivery systems for synergistic delivery of tumor therapy},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1111991}
}
EUVIMED